MapLight Therapeutics, Inc. Basic Shares Outstanding (Weighted Average)
MapLight Therapeutics, Inc. (MPLT) reported Basic Shares Outstanding (Weighted Average) of 45.43 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-13
- MapLight Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 45.43M shares, a 5853.96% increase year-over-year.
- MapLight Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 45.28M shares, a 5844.97% increase year-over-year.
- MapLight Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 32.41M shares, a 4165.84% increase year-over-year.
- MapLight Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 791.13K shares, a 4.34% increase year-over-year.
- MapLight Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 8.68M shares, a 1079.16% increase from fiscal 2024.
- MapLight Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 736.18K shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 45.43M shares 10-Q · filed 2026-08-13 | 45.35M shares 10-Q · filed 2026-08-13 | 41.04M shares derived: average of 3 quarters · filed 2026-08-13 | 30.98M shares derived: average of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | 45.28M shares 10-Q · filed 2026-05-14 | 38.84M shares derived: average of 2 quarters · filed 2026-05-14 | 26.16M shares derived: average of 3 quarters · filed 2026-05-14 | 19.81M shares derived: average of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | 32.41M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | 16.60M shares derived: average of 2 quarters · filed 2026-03-26 | 11.32M shares derived: average of 3 quarters · filed 2026-08-13 | 8.68M shares 10-K · filed 2026-03-26 |
| 2025-09-30 | 791.13K shares 10-Q · filed 2025-12-04 | 777.09K shares derived: average of 2 quarters · filed 2026-08-13 | 772.03K shares 10-Q · filed 2025-12-04 | 768.86K shares derived: average of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | 763.04K shares 10-Q · filed 2026-08-13 | 762.33K shares 10-Q · filed 2026-08-13 | 761.44K shares derived: average of 3 quarters · filed 2026-08-13 | 760.63K shares derived: average of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | 761.60K shares 10-Q · filed 2026-05-14 | 760.64K shares derived: average of 2 quarters · filed 2026-05-14 | 759.83K shares derived: average of 3 quarters · filed 2026-05-14 | |
| 2024-12-31 | 759.68K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | 758.94K shares derived: average of 2 quarters · filed 2026-03-26 | 736.18K shares 10-K · filed 2026-03-26 | |
| 2024-09-30 | 758.20K shares 10-Q · filed 2025-12-04 | 728.34K shares 10-Q · filed 2025-12-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |